Chemours Company Overview
Chemours Company Target Price
Analysts' 12-month price predictions for CC.
Share Price
$15.09
Average Target Price
$17.00
12.7% upside
12.7% upside1 analysts in the last 4 months
High: $17 | Low: $17
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-05-07 | UBSJoshua Spector | $17 | 12.7% upside |  |
| 2025-04-15 | Mizuho SecuritiesJohn Roberts | $15 |  0.6% downside | |
| 2024-10-11 | RBC CapitalArun Viswanathan | $28 | 85.6% upside | |
| 2024-10-07 | BMO CapitalJohn McNulty | $32 | 112.1% upside | |
| 2024-08-06 | BMO CapitalJohn McNulty | $30 | 98.8% upside | |
| 2024-06-07 | Mizuho SecuritiesJohn Roberts | $25 | 65.7% upside | |
| 2024-05-29 | UBSRich Hilliker | $31 | 105.4% upside | |
| 2024-04-09 | BMO CapitalJohn McNulty | $34 | 125.3% upside | |
| 2024-04-01 | UBSJoshua Spector | $28 | 85.6% upside | |
| 2024-04-01 | CFRAEmily Nassedd Mitsch | $18 | 19.3% upside | |
| 2024-03-13 | D.A. DavidsonLinda Bolton Weiser | $24 | 59% upside | |
| 2023-12-01 | RBC CapitalArun Viswanathan | $40 | 165.1% upside | |
| 2023-10-30 | Morgan StanleyVincent Andrews | $33 | 118.7% upside | |
| 2023-01-10 | RBC CapitalArun Viswanathan | $33 | 118.7% upside | |
| 2022-05-04 | RBC Capital | $48 | 218.1% upside | |
| 2021-05-20 | Bank of America SecuritiesMatthew DeYoe | $42 | 178.3% upside | |
| 2021-05-10 | Morgan StanleyVincent Andrews | $35 | 131.9% upside | |
| 2021-05-06 | Argus ResearchDavid Coleman | $40 | 165.1% upside | |